Heart Disease Trial, Recruiting (NCT07713017)

Heart Disease Trial, Recruiting NCT07713017 Sponsor: Riphah International University Condition: Heart Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07713017 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Heart Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People of any gender (male or female) may be considered.
People who have had a coronary artery bypass graft (CABG) — a type of heart surgery — that went smoothly, with no complications during or after the operation.
People who are willing to take part in a Phase II cardiac rehabilitation program (a structured recovery and exercise program for heart patients).
People between the ages of 30 and 60 years old.
People who have no problems or conditions affecting their muscles, bones, or joints.

Who may not be able to join:

People whose heart failure is unstable, or who experience symptoms such as chest pain or signs of reduced blood flow to the heart.
People whose diabetes or high blood pressure is not well controlled.
People who have any condition affecting their movement or nervous system.
People who have a severe reduction in consciousness, a bone or joint problem, or seriously reduced blood flow to their limbs.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Arjumand Bano, MS, Riphah International University

Phone: 333826752

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07713017

Sponsor: Riphah International University

Phase: Not Applicable

Status: Recruiting

Condition: Heart Disease

Trial contact: 333826752

More information: https://clinicaltrials.gov/study/NCT07713017

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People of any gender (male or female) may be considered.
People who have had a coronary artery bypass graft (CABG) — a type of heart surgery — that went smoothly, with no complications during or after the operation.
People who are willing to take part in a Phase II cardiac rehabilitation program (a structured recovery and exercise program for heart patients).
People between the ages of 30 and 60 years old.
People who have no problems or conditions affecting their muscles, bones, or joints.

Who may not be able to join:

People whose heart failure is unstable, or who experience symptoms such as chest pain or signs of reduced blood flow to the heart.
People whose diabetes or high blood pressure is not well controlled.
People who have any condition affecting their movement or nervous system.
People who have a severe reduction in consciousness, a bone or joint problem, or seriously reduced blood flow to their limbs.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Riphah International University

Registry

ClinicalTrials.gov

Start date

1 June 2026

Est. completion

1 August 2026

Where this trial is recruiting

🇵🇰 Pakistan

Primary endpoints

Six-Minute Walk Test (6MWT); Step test; Vo2 max

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov